TrialPharmacoEconomics2018

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.

Yasuhiro Hagiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.